(Updates with additional details in the third and fourth paragraphs.)
Novartis (NVS) plans to invest $23 billion in building and expanding 10 facilities in the US over the next five years in response to possible drug import tariffs under the Trump administration, Reuters reported Thursday, citing the company.
The company plans to construct six new manufacturing plants, including factories for raw pharmaceutical ingredients, and a new research and development site in San Diego, California, according to the report.
The projects, set for completion over the next five years, are expected to create over 1,000 specialized jobs and an additional 3,000 support and construction jobs, according to Reuters.
The company has reportedly not decided on exact locations for the new manufacturing sites.
Novartis did not immediately respond to a request for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 103.71, Change: -0.14, Percent Change: -0.14
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。